Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8341)
All Articles published online
|
Publishing Process of This Article
|
Apr 7, 2015 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ferrusquía J, Pérez-Martínez I, Gómez de la Torre R, Fernández-Almira ML, de Francisco R, Rodrigo L, Riestra S. Gastroenterology case report of mesalazine-induced cardiopulmonary hypersensitivity. World J Gastroenterol 2015; 21(13): 4069-4077 [PMID: 25852295 DOI: 10.3748/wjg.v21.i13.4069] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i13/4069.htm |
| Number | Citing Articles |
| 1 |
Izaskun Pizarro Carbajo, Alfonso Gutiérrez Macías, Markel Cea Gómez, Itxaso Lombide Aguirre. Fever induced by mesalazine. Gastroenterología y Hepatología (English Edition) 2018; 41(4): 261 doi: 10.1016/j.gastre.2018.04.006
|
| 2 |
Nicole Tejeda Taveras , Arlenys Rivera Martinez, Ram Kumar, Amna Jamil, Besham Kumar. Pulmonary Manifestations of Inflammatory Bowel Disease. Cureus 2021; doi: 10.7759/cureus.14216
|
| 3 |
Ferdinando D’Amico, Ernesto Fasulo, Vipul Jairath, Kristine Paridaens, Laurent Peyrin-Biroulet, Silvio Danese. Management and treatment optimization of patients with mild to moderate ulcerative colitis. Expert Review of Clinical Immunology 2024; 20(3): 277 doi: 10.1080/1744666X.2023.2292768
|
| 4 |
Qian Xie, Hongyan Li, Rong Ma, Mihong Ren, Yong Li, Jinxiu Li, Hai Chen, Zhuoping Chen, Daoyin Gong, Jian Wang. Effect of Coptis chinensis franch and Magnolia officinalis on intestinal flora and intestinal barrier in a TNBS-induced ulcerative colitis rats model. Phytomedicine 2022; 97: 153927 doi: 10.1016/j.phymed.2022.153927
|
| 5 |
|
| 6 |
Marianna M. Henry, Terry L. Noah. Kendig's Disorders of the Respiratory Tract in Children. 2019; : 876 doi: 10.1016/B978-0-323-44887-1.00059-6
|
| 7 |
Jina Yeo, Hyun Sun Woo, Sang Min Lee, Yoon Jae Kim, Kwang An Kwon, Dong Kyun Park, Jung Ho Kim, Kyoung Oh Kim, Jun-Won Chung. Drug-induced eosinophilic pneumonia in a patient with Crohn's disease: diagnosis and treatment using fraction of exhaled nitric oxide. Intestinal Research 2017; 15(4): 529 doi: 10.5217/ir.2017.15.4.529
|
| 8 |
Takuro Sato, Manabu Tagawa, Isho Izumi, Takumi Kiwamoto, Ryo Sumazaki. Mesalazine‐induced lung injury in a child; the value of bronchoscopy. Pediatrics International 2021; 63(11): 1402 doi: 10.1111/ped.14640
|
| 9 |
Jiaxi Chen, Mengyue Pan, Jingjie Wang, Mengling Zhang, Mingmei Feng, Xiaoming Chai, Qi Zhang, Yang Sun. Hydroxysafflor yellow A protects against colitis in mice by suppressing pyroptosis via inhibiting HK1/NLRP3/GSDMD and modulating gut microbiota. Toxicology and Applied Pharmacology 2023; 467: 116494 doi: 10.1016/j.taap.2023.116494
|
| 10 |
P. Sehgal, J.‐F. Colombel, A. Aboubakr, N. Narula. Systematic review: safety of mesalazine in ulcerative colitis. Alimentary Pharmacology & Therapeutics 2018; 47(12): 1597 doi: 10.1111/apt.14688
|
| 11 |
Irfan A. Rather, Vivek K. Bajpai, Lew L. Ching, Rajib Majumder, Gyeong-Jun Nam, Nagaraju Indugu, Prashant Singh, Sanjay Kumar, Nahid H. Hajrah, Jamal S.M. Sabir, Majid Rasool Kamli, Yong-Ha Park. Effect of a bioactive product SEL001 from Lactobacillus sakei probio65 on gut microbiota and its anti-colitis effects in a TNBS-induced colitis mouse model. Saudi Journal of Biological Sciences 2020; 27(1): 261 doi: 10.1016/j.sjbs.2019.09.004
|
| 12 |
Philippe Camus, Thomas V. Colby. Pulmonary Manifestations of Systemic Diseases. 2019; doi: 10.1183/2312508X.10015019
|
| 13 |
Izaskun Pizarro Carbajo, Alfonso Gutiérrez Macías, Markel Cea Gómez, Itxaso Lombide Aguirre. Fiebre por mesalazina. Gastroenterología y Hepatología 2018; 41(4): 261 doi: 10.1016/j.gastrohep.2017.03.009
|
| 14 |
Ahtshamullah Chaudhry, Jawad Noor, Ghulam Fatima, Saima Batool, Riwad Noor. Mesalamine - A Revered Drug for Inflammatory Bowel Disease With Detrimental Effects on the Lung and Heart. Cureus 2023; doi: 10.7759/cureus.43567
|
| 15 |
Andrei Tudor Cernomaz, Gabriela Bordeianu, Cristina Terinte, Cristina Maria Gavrilescu. Nonasthmatic eosinophilic bronchitis in an ulcerative colitis patient – a putative adverse reaction to mesalazine: A case report and review of literature. World Journal of Clinical Cases 2020; 8(18): 4162-4168 doi: 10.12998/wjcc.v8.i18.4162
|
| 16 |
G. N. Yankinа, L. V. Gorlenko, E. V. Loshkova, E. I. Kondratyeva, E. Yu. Tuteva, A. A. Terenteva, V. A. Zhelev, E. V. Mikhalev, T. A. Shemyakinа, T. S. Krivonogova, N. A. Ryzhakova, E. V. Romanova. Mesalazin-induced eosinophilic pneumonia in a 15-year-old boy with ulcerative colitis. Bulletin of Siberian Medicine 2019; 18(3): 245 doi: 10.20538/1682-0363-2019-3-245-257
|
| 17 |
Feng Zhou, Guo Dong Zhang, Yang Tan, Shi An Hu, Qun Tang, Gang Pei. NOD-like receptors mediate homeostatic intestinal epithelial barrier function: promising therapeutic targets for inflammatory bowel disease. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231176889
|